INT Medical Reports No Change in Share Capital for April 2026

Bulletin Express05-06

Shanghai INT Medical Instruments Co., Ltd. (INT Medical) filed its monthly return for the period ended 30 April 2026, confirming that the company’s share structure and public-float status remained unchanged during the month.

INT Medical’s issued share capital stayed at 211.20 million shares (par value: RMB1 each), split between 139.41 million H shares listed on the Hong Kong Stock Exchange and 71.79 million domestic shares. No treasury shares were outstanding.

The company affirmed compliance with the Main Board’s minimum public-float requirement, maintaining at least 25% of H shares in public hands as of 30 April 2026.

INT Medical reported no share options, warrants, convertible instruments, or other agreements that would result in additional share issuance, and there were no repurchases, cancellations, or transfers of treasury shares during the month.

Chairman and Executive Director Liang Dongke signed the filing on 6 May 2026, attesting that all regulatory obligations associated with the company’s share capital remain fully satisfied.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment